Cardiovascular Drugs and Therapy

, Volume 6, Issue 2, pp 103–110 | Cite as

Cholesterol biosynthesis and metabolism

  • David W. Russell
Editorial Comment on the Value of Lowering Blood Cholesterol


Cholesterol plays an essential role in cell membrane synthesis and in cell growth and differentiation. In mammalian cells, cholesterol can be synthesized from acetate precursors or taken up from dietary or exogenous sources. The major catabolic route for disposal of cholesterol involves conversion into excretable bile acids. The maintenance of cholesterol homeostasis is influenced and carefully controlled by multiple feedback mechanisms. The key regulatory targets of these feedback mechanisms are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase in cholesterol biosynthesis, the low-density lipoprotein (LDL) receptor in cholesterol uptake, and cholesterol 7α-hydroxy-lase in cholesterol catabolism. The elucidation of regulatory mechanisms in cholesterol metabolism has been greatly facilitated by the discovery of a new class of lipid-lowering drugs, the HMG-CoA reductase inhibitors. In addition to proving therapeutically useful in the treatment of hypercholesterolemia, these drugs have revealed novel regulatory steps in cholesterol metabolism and several new targets for future drug development. This manuscript reviews recent developments in the cholesterol biosynthetic pathway and the regulatory mechanisms that maintain cholesterol homeostasis.

Key Words

cholesterol biosynthesis autoregulation homeostasis 3-hydroxy-3-methylglutaryl coenzyme A HMG-CoA 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brown MS, Kovanen PT, Goldstein JL. Regulation of plasma cholesterol by lipoprotein receptors. Science 1981;212:628–635.Google Scholar
  2. 2.
    Dietschy JM. Regulation of cholesterol metabolism in man and in other species. Klin Wochesnschr 1984;62:338–345.Google Scholar
  3. 3.
    Dietschy JM, Wilson JD. Regulation of cholesterol metabolism (three parts). N Engl J Med 1970;282:1128–1138, 1179–1183, 1241–1249.Google Scholar
  4. 4.
    Siperstein MD. Role of cholesterologenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res 1984;25:1462–1468.Google Scholar
  5. 5.
    Andersen M, Dietschy JM. Regulation of sterol synthesis in 16 tissues of rat. J Biol Chem 1977;252:3646–3651.Google Scholar
  6. 6.
    Parker TS, McNamara DJ, Brown C, et al. Mevalonic acid in human plasma: Relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proc Natl Acad Sci USA 1982;79:3037–3041.Google Scholar
  7. 7.
    Angelin B, Einarsson K. Regulation of HMG-CoA reductase in human liver. In: Preiss E, ed. Regulation of HMG-CoA reductase. Orlando, FL: Academic Press, 1985:281–320.Google Scholar
  8. 8.
    Carulli N, Tripodi A, Carubbi F. Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man. Clin Chim Acta 1989;83:77–82.Google Scholar
  9. 9.
    Story JA. cholesterol synthesis and degradation. Lab Res Methods Biol Med 1984;10:217–230.Google Scholar
  10. 10.
    Dietschy JM, Spady DK. Measurement of rates of cholesterol synthesis using tritiated H2O. J Lipid Res 1984;25:1469–1476.Google Scholar
  11. 11.
    Jones PJH, Schoeller DA. Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res 1990;31:667–673.Google Scholar
  12. 12.
    Edwards PA, Fogelman AM. Studies on purified mammalian HMG-CoA reductase and regulation of enzyme activity. In: Preiss E, ed. Regulation of HMG-CoA reductase. Orlando, FL: Academic Press, 1985:133–148.Google Scholar
  13. 13.
    Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425–430.Google Scholar
  14. 14.
    Panini SR, Rogers DH, Rudney H. Regulation of HMG-CoA reductase and the biosynthesis of nonsteroid prenyl derivatives. In: Preiss E, ed. Regulation of HMG-CoA reductase. Orlando, FL: Academic Press, 1985:149–181.Google Scholar
  15. 15.
    Huneeus VQ, Wiley MH, Siperstein MD. Isopentenyladenine as a mediator of mevalonate-regulated DNA replication. Proc Natl Acad Sci USA 1980;77:5842–5846.Google Scholar
  16. 16.
    Schroepfer GJ. Sterol biosynthesis. Ann Rev Biochem 1982;51:555–585.Google Scholar
  17. 17.
    Davis RA, Sinensky M, Junker LH. Regulation of cholesterol synthesis and the potential for its pharmacologic manipulation. Pharmacol Ther 1989;43:221–236.Google Scholar
  18. 18.
    Rudney H, Sexton RC. Regulation of cholesterol biosynthesis. Ann Rev Nutr 1986;6:245–272.Google Scholar
  19. 19.
    Björkhem I. Mechanism of bile acid synthesis in mammalian liver. In: Danielsson H, Sjövall J, eds. Sterols and bile acids. Amsterdam, Holland: Elsevier Press, 1985:231–278.Google Scholar
  20. 20.
    Jelinek DF, Andersson S, Slaughter CA, Russell DW. Cloning and regulation of cholesterol 7α-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem 1990;265:8190–8197.Google Scholar
  21. 21.
    Huneeus VQ, Wiley MH, Siperstein MD. Essential role for mevalonate synthesis in DNA replication. Proc Natl Acad Sci USA 1979;76:5056–5060.Google Scholar
  22. 22.
    Cuthbert JA, Lipsky PE. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation. J Biol Chem 1990;265:18568–18575.Google Scholar
  23. 23.
    Farnsworth CC, Wolda SL, Gelb MH, Glomset JA. Human lamin B contains a farnesylated cysteine residue. J Biol Chem 1989;264:20422–20429.Google Scholar
  24. 24.
    McCormick F. GTP binding and growth control. Curr Opin Cell Bio 1990;2:181–184.Google Scholar
  25. 25.
    Hancock JF, Magee AI, Childs JE, Marshall CJ. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989;57:1167–1177.Google Scholar
  26. 26.
    Mumby SM, Casey PJ, Gilman AG, et al. G protein γ subunits contain a 20-carbon isoprenoid. Proc Natl Acad Sci USA 1990;87:5873–5877.Google Scholar
  27. 27.
    Finegold AA, Schafer WR, Rine J, et al. Common modifications of trimeric G proteins and ras protein: Involvement of polyisoprenylation. Science 1990;249:165–169.Google Scholar
  28. 28.
    Schafer WR, Trueblood CE, Yang C-C, et al. Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the ras protein. Science 1990;249:1133–1139.Google Scholar
  29. 29.
    Brown MS, Kovanen PT, Goldstein JL. Receptor-mediated uptake of lipoprotein-cholesterol and its utilization for steroid synthesis in the adrenal cortex. Rec Prog Horm Res 1979;35:215–257.Google Scholar
  30. 30.
    Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;323:34–47.Google Scholar
  31. 31.
    Yamamoto T, Davis CG, Brown MS, et al. The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 1984;39:27–38.Google Scholar
  32. 32.
    Russell DW, Brown MS, Goldstein JL. Different combinations of cysteine-rich repeats mediate binding of low-density lipoprotein receptors to two different proteins. J Biol Chem 1989;264:21682–21688.Google Scholar
  33. 33.
    Brown MS, Anderson RGW, Goldstein JL. Recycling receptors: The round trip itinerary of migrant membrane proteins. Cell 1983;32:663–667.Google Scholar
  34. 34.
    Russell DW, Yamamoto T, Schneider WJ, et al. cDNA cloning of the bovine low-density lipoprotein receptor: Feedback regulation of a receptor mRNA. Proc Natl Acad Sci USA 1983;80:7501–7505.Google Scholar
  35. 35.
    Ma PTS, Gil G, Südhof TC, et al. Mevinolin, an inhibitor of cholesterol synthesis, includes mRNA for LDL receptors in livers of hamsters and rabbits. Proc Natl Acad Sci USA 1986;83:8370–8374.Google Scholar
  36. 36.
    Liscum L, Finer-Moore J, Stroud RM, et al. Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum. J Biol Chem 1985;260:522–530.Google Scholar
  37. 37.
    Luskey KL, Stevens B. Human 3-hydroxy-3-methyl-glutaryl coenzyme A reductase: Conserved domains responsible for catalytic activity and sterol-regulated degradations. J Biol Chem 1985;260:10271–10277.Google Scholar
  38. 38.
    Luskey KL, Regulation of cholesterol synthesis: Mechanism for control of HMG-CoA reductase. Recent Prog Horm Res 1988;44:35–51.Google Scholar
  39. 39.
    Gibson DM. Reversible phosphorylation of hepatic HMG-CoA reductase in endocrine and feedback control of cholesterol biosynthesis. In: Preiss E, ed. Regulation of HMG-CoA reductase. Grlando, FL: Academic Press, 1985:80–132.Google Scholar
  40. 40.
    Osborne TF, Goldstein JL, Brown MS. 5′ end of HMB CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription. Cell 1985;42:203–212.Google Scholar
  41. 41.
    Nakanishi M, Goldstein JL, Brown MS. Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Mevalonate-derived product inhibits translation of mRNA and accelerated degradation of enzyme. J Biol Chem 1988;263:8929–8937.Google Scholar
  42. 42.
    Panini SR, Schnitzer-Polokoff R, et al. Sterol-independent regulation of 3-hydroxy-3-methylglutaryl-CoA reductase by mevalonate in Chinese hamster ovary cells. J Biol Chem 1989;264P11044–11052.Google Scholar
  43. 43.
    Gil G, Faust JR, Chin DJ, et al. Membrane-bound domain of HMG-CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell 1985;41:249–258.Google Scholar
  44. 44.
    Ingebritsen TS, Gibson DM. Reversible phosphorylation of hydroxymethylglutaryl coenzyme A reductase. In: Cohen P, ed. Molecular aspects of cellular regeneration. North-Holland, Amsterdam: Elsevier Press, 1980:63–93.Google Scholar
  45. 45.
    Clarke CF, Fogelman AM, Edwards PA. Diurnal rhythm of rat liver mRNAs encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem 1984;259:10439–10447.Google Scholar
  46. 46.
    Simonet WS, Ness GC. Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutarylcoenzyme A reductase by thyroid hormones. J Biol Chem 1988;263:12448–12453.Google Scholar
  47. 47.
    Brown MS, Goldstein JL. Multivalent feedback regulation of HMG-CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 1980; 21:505–517.Google Scholar
  48. 48.
    Osborne TF, Gil G, Goldstein JL, Brown MS. Operatorconstitutive mutation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter abolishes protein binding to sterol regulatory element. J Biol Chem 1988;263:3380–3387.Google Scholar
  49. 49.
    Smith JR, Osborne TF, Brown MS, et al. Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Biol Chem 1988; 263:18480–18487.Google Scholar
  50. 50.
    Ashby MN, Edwards PA. Identification and regulation of a rat liver cDNA encoding farnesyl pyrophosphate synthetase. J Biol Chem 1989;264:635–640.Google Scholar
  51. 51.
    Tanaka RD, Lee LY, Schafer BL, et al. Molecular cloning of mevalonate kinase and regulation of its mRNA levels in rat liver. Proc Natl Acad Sci USA 1990;87:2872–2876.Google Scholar
  52. 52.
    Danielsson H, Einarsson K, Johansson G. Effect of biliary drainage on individual reactions in the conversion of cholesterol to taurocholic acid. Eur J Biochem 1967;2:44–49.Google Scholar
  53. 53.
    Noshiro M, Nishimoto M, Morohashi K, Okuda K. Molecular cloning of cDNA for cholesterol 7α-hydroxylase from rat liver microsomes. FEBS Lett 1989;257:97–100.Google Scholar
  54. 54.
    Li YC, Wang DP, Chiang JYL. Regulation of cholesterol 7α-hydroxylase in the liver: Cloning, sequencing, and regulation of cholesterol 7α-hydroxylase mRNA. J Biol Chem 1990;265:12012–12019.Google Scholar
  55. 55.
    Nguyen LB, Shefer S, Salen G, et al. Purification of cholesterol 7α-hydroxylase from human and rat liver and production of inhibiting polyclonal antibodies. J Biol Chem 1990; 265:4541–4546.Google Scholar
  56. 56.
    Chiang JYL, Miller WF, Lin G-M. Regulation of cholesterol 7α-hydroxylase in the liver. J Biol Chem 1990;265:3889–3897.Google Scholar
  57. 57.
    Noshiro M, Nishimoto M, Okuda K. Rat liver cholesterol 7α-hydroxylase. J Biol Chem 1990;265:10036–10041.Google Scholar
  58. 58.
    Sundseth SS, Waxman DJ, Hepatic P-450 cholesterol 7α-hydroxylase: Regulation in vivo at the protein and mRNA level in response to mevalonate, diurnal rhythm, and bile acid feedback. J Biol Chem 1990;265:15090–15095.Google Scholar
  59. 59.
    Jelinek DF, Russell DW. Structure of the rat gene encoding cholesterol 7α-hydroxylase. Biochemistry 1990;29:81–85.Google Scholar
  60. 60.
    Endo A, Kuroda M, Tanzawa K. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites having hypocholesterolemic activity. FEBS Lett 1976;72:323–326.Google Scholar
  61. 61.
    Chin DJ, Luskey KL, Faust JR, et al. Molecular cloning of 3-hydroxy-3-methylglutaryl coenzyme A reductase and evidence for regulation of its mRNA. Proc Natl Acad Sci USA 1982;79:7704–7708.Google Scholar
  62. 62.
    Grundy S. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 1988;319:24–32.Google Scholar
  63. 63.
    Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289–1298.Google Scholar
  64. 64.
    Achor RWP, Winkelmann RK, Perry HO. Cutaneous side effects from use of triparanol (MED-29); Preliminary data on ichthyosis and loss of hair. Proc Mayo Clin 1961;36:217–228.Google Scholar
  65. 65.
    Laughlin RC, Carey TF. Cataracts in patients treated with triparanol. JAMA 1962;181:339–340.Google Scholar
  66. 66.
    Hobbs HH, Russell DW, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: Mutational analysis of a membrane protein. Annu Rev Genet 1990;24:133–170.Google Scholar

Copyright information

© Kluwer Academic Publishers 1992

Authors and Affiliations

  • David W. Russell
    • 1
  1. 1.Department of Molecular GeneticsUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations